from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0851c/-

LFCtreatmentdescriptionclass of inhibitor

0.240

Amikacinug/mL Amikacintranslation

0.071

Cap5-10ug/mL Capreomycintranslation

0.350

Rox10-50 ug/mL Roxithromycintranslation

-0.811

SM2-5 ug/mL Streptomycintranslation

-2.916

Tet5-10 ug/mL Tetracyclinetranslation

0.595

Rif0.2-5ug/mL Rifampicintranscription

-0.271

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.588

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.357

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.358

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.799

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.089

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.443

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.265

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.461

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.847

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.152

Nigericin50 uM Nigericinrespiration

-0.463

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.466

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-1.151

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.024

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.510

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.116

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.279

NRP_1Non-replicating persistence stage 1dosRassociated

-0.115

Amp0.2mg/mL AmpicillincellWall

0.204

Cephalexin20-100 ug/mL CephalexincellWall

0.202

Cerulenin0.32-5 ug/mL CerulenincellWall

0.297

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.862

EMB10-20 ug/mL EthambutolcellWall

0.520

Eta12-40 ug/mL EthionamidecellWall

-0.117

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.316

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.482

BZA0.12 mg/mL BenzamidearomaticAmides

0.447

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.188

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.665

H2O24 mM hydrogen peroxideDNAdamaging

0.317

Levo10 ug/mL LevofloxacinDNAdamaging

-0.156

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.130

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.134

Antimycin12.5-50 ug/mL Antimycin A?

0.218

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.337

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.368

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.144

PA8240.2-2 ug/mL PA-824?

-0.157

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.179

Verapamil50 uM Verapamil?

-0.436

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.075

methoxatin10-20 ug/mL Methoxatin?